Integrated Approach to Spray Drying for Optimized Oral and Vaccine Formulations
Date: Wednesday, May 18, 2021
Time: 11 am ET
Developers and manufacturers are increasingly adopting spray drying as a formulation enabling technology to develop amorphous solid dispersion of poorly soluble drugs. In addition, spray drying seems to be a promising approach for the stabilization of vaccines. However, poor understanding of physicochemical stability between the API and excipients, manufacturability and downstream processability could limit its use in commercial manufacturing.
In this webinar, an academic expert will discuss optimal design space parameters involved in developing spray dried dispersion of poorly soluble drugs for oral and vaccine delivery. A Catalent expert will then highlight the influence of key formulation and process variables on the physical structure and stability of spray dried small molecules, to ensure a seamless scale-up to clinical manufacturing and commercial launch.
Key Learning Objectives:
- Understand the optimal design space for early evaluation of spray drying of poorly soluble drugs for oral and vaccine delivery
- Learn more about the interplay between key formulation/process variables and product quality to ensure seamless scale-up
- Discover how integrated spray drying services can help minimize risk and save valuable time in development and manufacturing
Pavan Muttil, Ph.D.
Dept. of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico
Stephie Lee, M.S.
Associate Director, Pharmaceutics,